InVivo Therapeutics adds 4th clinical site

InVivo Therapeutics adds the 4th site to a feasibility study of its biodegradable implant to treat acute spinal cord injuries.

InVivo Therapeutics Corp.

News Well, Clinical Trials, Regenerative Medicine, Spinal, Trauma

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1OQOOiL